On the fly News and insights, exclusive to thefly.com

AGN

Bought by ABBV

$129.65 /

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41 /

-0.37 (-0.47%)

09:07
06/25/19
06/25
09:07
06/25/19
09:07

Fly Intel: Pre-market Movers

HIGHER: Allergan (AGN), up 31% after entering into a definitive transaction agreement under which AbbVie (ABBV) will acquire the company in a cash and stock transaction for an equity value of approximately $63B... Pyxus (PYX), up 15% after Imperial Capital analyst Mary Ross Gilbert initiated the stock with an Outperform rating and $71 price target, citing her view of the potential of the company to be a fast growing franchise for years given its combination of cultivation, extraction and e-liquids capabilities... ArQule (ARQL), up 3% after its 9.25M share spot secondary priced at $9.75 per share. UP AFTER EARNINGS: Lennar (LEN), up 4%. LOWER: AbbVie, down 10% after announcing its $63B cash and stock deal to acquire Allergan... Brighthouse Financial (BHF), down 9% after Credit Suisse analyst Andrew Kligerman downgraded shares to Underperform and Goldman Sachs analyst Alex Scott downgraded the stock to Sell... Pivotal Software (PVTL), down 3% after BofA/Merrill Lynch analyst Nikolay Beliov downgraded the stock to Underperform... Sally Beauty (SBH), down another 3% after yesterday's announcement of the launch of Amazon's (AMZN) professional beauty store... Aldeyra (ALDX), down 24% after reporting statistical significance was not achieved for endpoints in its SOLACE trial.

AGN

Bought by ABBV

$129.65 /

-1.32 (-1.01%)

ABBV

AbbVie

$78.41 /

-0.37 (-0.47%)

PYX

Pyxus

$13.42 /

-1.1 (-7.58%)

ARQL

ArQule

$10.00 /

-0.48 (-4.58%)

LEN

Lennar

$51.41 /

+0.09 (+0.18%)

BHF

Brighthouse Financial

$38.10 /

-0.01 (-0.03%)

PVTL

Pivotal Software

$11.35 /

-0.15 (-1.30%)

SBH

Sally Beauty

$12.30 /

-2.49 (-16.84%)

ALDX

Aldeyra

$7.08 /

-0.29 (-3.93%)

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

  • 11

    Jul

  • 16

    Sep

  • 25

    Jun

AGN Bought by ABBV
$129.65 /

-1.32 (-1.01%)

06/25/19 SVB Leerink
Bid of $188 for Allergan 'too low,' others may pursue as well, says SVB Leerink
06/25/19 Wells Fargo
Deals with premiums like Allergan's 'rarely killed,' says Wells Fargo
06/25/19 Piper Sandler
Piper says 'willing to listen' to AbbVie reasoning for Allergan acquisition
06/25/19 Mizuho
Allergan price target lowered to $171 from $194 at Mizuho
ABBV AbbVie
$78.41 /

-0.37 (-0.47%)

06/13/19 Piper Sandler
AbbVie rheumatology franchise feedback incrementally positive, says Piper
PYX Pyxus
$13.42 /

-1.1 (-7.58%)

06/25/19 Imperial Capital
Pyxus initiated with an Outperform at Imperial Capital
ARQL ArQule
$10.00 /

-0.48 (-4.58%)

06/19/19 RBC Capital
ArQule price target raised to $12 from $10 at RBC Capital
06/17/19 Roth Capital
ArQule price target raised to $20 from $10 at Roth Capital
06/14/19 Roth Capital
ArQule price target raised to $13 from $10 at Roth Capital
05/29/19 B. Riley FBR
ArQule price target raised to $11 from $6.75 at B. Riley FBR
LEN Lennar
$51.41 /

+0.09 (+0.18%)

06/18/19 Raymond James
KB Home downgraded to Underperform on 'rich' valuation at Raymond James
06/18/19 Raymond James
Lennar downgraded to Market Perform on 'rich' valuation, says Raymond James
06/18/19 Raymond James
Lennar downgraded to Market Perform from Outperform at Raymond James
06/17/19 Buckingham
Buckingham 'constructive' on Lennar, KB Home ahead of earnings reports
BHF Brighthouse Financial
$38.10 /

-0.01 (-0.03%)

06/25/19
Brighthouse Financial downgraded to Underperform on risk at Credit Suisse
06/25/19 Goldman Sachs
Brighthouse Financial downgraded to Sell from Neutral at Goldman Sachs
06/25/19 Credit Suisse
Brighthouse Financial downgraded to Underperform from Neutral at Credit Suisse
06/03/19 Citi
Citi recommends focusing on pair trades in Life Insurance
PVTL Pivotal Software
$11.35 /

-0.15 (-1.30%)

06/25/19 BofA
Pivotal Software downgraded to Underperform from Neutral at BofA/Merrill
06/05/19 Credit Suisse
Pivotal Software price target lowered to $20 from $25 at Credit Suisse
06/05/19 Needham
Pivotal Software price target lowered to $21 from $28 at Needham
06/05/19 Wedbush
Pivotal Software downgraded to Neutral from Outperform at Wedbush
SBH Sally Beauty
$12.30 /

-2.49 (-16.84%)

06/25/19 Oppenheimer
Amazon entrance to likely continue to depress Sally's multiple, says Oppenheimer
06/25/19 DA Davidson
Sally Beauty price target lowered to $14 from $16.50 at DA Davidson
06/24/19 Jefferies
Sally Beauty 'most exposed' to Amazon news, Ulta not hurt, says Jefferies
05/07/19 DA Davidson
Sally Beauty price target lowered to $16.50 from $19 at DA Davidson
ALDX Aldeyra
$7.08 /

-0.29 (-3.93%)

05/10/19 Canaccord
Aldeyra price target lowered to $20 from $35 at Canaccord
03/26/19 JonesTrading
Aldeyra price target raised to $38 from $32 at JonesTrading
03/26/19 JonesTrading
Aldeyra price target raised to $38 from $32 at JonesTrading
03/26/19 Citi
Citi boosts Aldeyra target to $28 from $23, closes catalyst watch

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.